Explore the words cloud of the REBOOT project. It provides you a very rough idea of what is the project "REBOOT" about.
The following table provides information about the project.
Coordinator |
NORAKER
Organization address contact info |
Coordinator Country | France [FR] |
Total cost | 3˙545˙000 € |
EC max contribution | 2˙481˙500 € (70%) |
Programme |
1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies) |
Code Call | H2020-SMEInst-2018-2020-2 |
Funding Scheme | SME-2 |
Starting year | 2019 |
Duration (year-month-day) | from 2019-11-01 to 2021-10-31 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | NORAKER | FR (VILLEURBANNE) | coordinator | 2˙481˙500.00 |
NORAKER develops first-in-class implants for regenerative orthopaedic surgery to offer full healing to patients suffering from a bone, ligament or tendon injury. With project REBOOT, NORAKER will create the market of bone regeneration surgery. Each year in Europe, 1,6 million people require orthopaedic surgery after a bone, ligament or tendon injury, with many more cases expected as population ages. The current implants (made of metallic or bioresorbable materials) show imperfect healing outcomes, leaving millions of patients with fragile bones and poor quality of life (with 30% of inflammation, 20% of revision surgery and millions suffering from chronic pain and musculoskeletal disorders, MSDs). It weights billions of follow-up costs on the community. Enter NORAKER’s biocomposite surgical implants, made of bioactive glass – a revolutionary ceramic – mixed with a synthetic polymer, both bioabsorbable. This technology shows disruptive regeneration action: it can recreate up to 100% of the native-like functional bone structure with no inflammation, no abnormal pain, no MSD and a very low re-operation rate (4%). Today this patented technology is adapted to knee cruciate ligaments regeneration (with a world-first biocomposite screw marketed in 2015). In a SME Instrument Phase 1 project (2018), NORAKER has validated the feasibility of a new biocomposite formula with broader perspectives of regeneration for tendon, ligament and bone injuries. The Phase 2 project will do the industrial scale-up of this biocomposite and launch the industrial production of the first range of implants for the bone trauma market. Their adoption will support the transition toward regenerative orthopaedic surgery and break the spiral of pain and MSDs, which too many patients are experiencing these days. With this disruptive offer, NORAKER will become a scale-up operating worldwide, with a large manufacturing capablity, international sales and turnover multiplied by 15 in five years.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "REBOOT" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "REBOOT" are provided by the European Opendata Portal: CORDIS opendata.
Tracworx is a data analytics tool that allows you to establish bottlenecks in your patient flow, while understanding your efficiencies and ultimately your true capacity.
Read MoreMANUBACK, the smart garment for operator protection in the field of Manual Handling of Goods
Read MoreINSIGHTS FOR TALENT ASSESSMENT USING COMPUTER VISION TECHNIQUES FROM NEURO PSYCHOLOGY
Read More